Q1 2019 Investor Conference Call

Thursday, April 25, 2019
Start at approx. 2:00 p.m. CEST (12:00 noon UTC)

Investor News April 25, 2019

First quarter of 2019:

Bayer: strong operational start to the year

Group sales increase 4.1 percent (Fx & portfolio adj.) to 13.015 billion euros / EBITDA before special items advances by 44.6 percent to 4.188 billion euros / Crop Science posts substantial sales and earnings gains following the acquisition / Pharmaceuticals shows encouraging sales and earnings growth / Consumer Health below the prior-year quarter, full-year outlook confirmed / Net income declines as expected by 36.5 percent to 1.241 billion euros, held back by special items related to the acquisition and restructuring / Core earnings per share increase 13.8 percent to 2.55 euros / Business outlook for 2019 confirmed MORE



Werner Baumann
CEO of Bayer AG

Audio recording of the investor conference call


Audio file

You can also play the audio recording on your mobile device.


Presentation charts

Quarterly Statement 1st Quarter 2019


Wolfgang Nickl
CFO of Bayer AG

Q1 2019 Analyst and Investor Briefing


Q1 2019 All in One Package for Investors and Analysts